Terms: = Breast cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Treatment
39 results:
1. Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes.
Franzoi MA; Aupomerol M; Havas J; Soldato D; Lambertini M; Massarotti C; Hang H; Pistilli B; Fasse L; Tredan O; Gillanders E; Joly F; Cottu P; Mouret-Reynier MA; Tarpin C; Arnaud A; Everhard S; Martin AL; Di Meglio A; Vaz-Luis I
ESMO Open; 2024 Feb; 9(2):102236. PubMed ID: 38350335
[TBL] [Abstract] [Full Text] [Related]
2. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ breast cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Wildiers H; Armstrong A; Cuypere E; Dalenc F; Dirix L; Chan S; Marme F; Schröder CP; Huober J; Duhoux FP; Vuylsteke P; Jager A; Brain E; Kuemmel S; Pápai Z; Menke-van der Houven van Oordt CW; Perjesi L; Mueller C; Brignone C; Triebel F
Clin Cancer Res; 2024 Feb; 30(3):532-541. PubMed ID: 37939105
[TBL] [Abstract] [Full Text] [Related]
3. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.
Chen XY; Li B; Wang Y; Jin J; Yang Y; Huang LH; Yang MD; Zhang J; Wang BY; Shao ZM; Ni T; Huang SL; Hu XC; Tao ZH
Cancer Commun (Lond); 2023 Sep; 43(9):1003-1026. PubMed ID: 37434394
[TBL] [Abstract] [Full Text] [Related]
4. Biomedical Indicators of Patients with Non-Puerperal Mastitis: A Retrospective Study.
Shi L; Wu J; Hu Y; Zhang X; Li Z; Xi PW; Wei JF; Ding Q
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432503
[TBL] [Abstract] [Full Text] [Related]
5. Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human breast cancer.
Hochman J; Braitbard O
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366533
[TBL] [Abstract] [Full Text] [Related]
6. Clinical outcomes associated with npm1 mutations in patients with relapsed or refractory AML.
Issa GC; Bidikian A; Venugopal S; Konopleva M; DiNardo CD; Kadia TM; Borthakur G; Jabbour E; Pemmaraju N; Yilmaz M; Short NJ; Maiti A; Sasaki K; Masarova L; Pierce S; Takahashi K; Tang G; Loghavi S; Patel K; Andreeff M; Bhalla K; Garcia-Manero G; Ravandi F; Kantarjian H; Daver N
Blood Adv; 2023 Mar; 7(6):933-942. PubMed ID: 36322818
[TBL] [Abstract] [Full Text] [Related]
7. Health-Related Quality of Life in Patients with breast cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.
Gonzalez L; Bardach A; Palacios A; Peckaitis C; Ciapponi A; Pichón-Riviere A; Augustovski F
Oncologist; 2021 May; 26(5):e794-e806. PubMed ID: 33554426
[TBL] [Abstract] [Full Text] [Related]
8. G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D.
Sok V; Jacinto AZ; Peng N; Eldemerdash M; Le L; Tran PD; Feng LF; Patel JR; Gi M; Ammon JC; So CH
Biochem Cell Biol; 2021 Aug; 99(4):508-518. PubMed ID: 33507833
[TBL] [Abstract] [Full Text] [Related]
9. Exercise in older women with breast cancer during systemic therapy: study protocol of a randomised controlled trial (BREACE).
Andersen HH; Mikkelsen MK; Lundager I; Lund CM; Johansen JS; Vinther A; Bogh Juhl C; Zerahn B; Ragle AM; Nielsen DL
BMJ Open; 2020 Oct; 10(10):e038674. PubMed ID: 33033025
[TBL] [Abstract] [Full Text] [Related]
10. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
[TBL] [Abstract] [Full Text] [Related]
11. PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases.
Beaton L; Nica L; Tyldesley S; Sek K; Ayre G; Aparicio M; Gondara L; Speers C; Nichol A
Radiat Oncol; 2020 Jun; 15(1):136. PubMed ID: 32487183
[TBL] [Abstract] [Full Text] [Related]
12. Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study.
Di Meglio A; Michiels S; Jones LW; El-Mouhebb M; Ferreira AR; Martin E; Matias M; Lohmann AE; Joly F; Vanlemmens L; Everhard S; Martin AL; Lemonnier J; Arveux P; Cottu PH; Coutant C; Del Mastro L; Partridge AH; André F; Ligibel JA; Vaz-Luis I
Breast; 2020 Aug; 52():23-32. PubMed ID: 32344296
[TBL] [Abstract] [Full Text] [Related]
13. APE1 and npm1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC.
Malfatti MC; Gerratana L; Dalla E; Isola M; Damante G; Di Loreto C; Puglisi F; Tell G
J Exp Clin Cancer Res; 2019 Jul; 38(1):309. PubMed ID: 31307523
[TBL] [Abstract] [Full Text] [Related]
14. Quality of Life in Patients with breast cancer-Related Lymphedema and Reconstructive breast Surgery.
Penha TR; Botter B; Heuts EM; Voogd AC; von Meyenfeldt MF; van der Hulst RR
J Reconstr Microsurg; 2016 Jul; 32(6):484-90. PubMed ID: 26919383
[TBL] [Abstract] [Full Text] [Related]
15. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (npm1).
Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
[TBL] [Abstract] [Full Text] [Related]
16. Time-Varying Effects of breast cancer Adjuvant Systemic Therapy.
Jatoi I; Bandos H; Jeong JH; Anderson WF; Romond EH; Mamounas EP; Wolmark N
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26518884
[TBL] [Abstract] [Full Text] [Related]
17. Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells.
Hiľovská L; Jendželovský R; Jendželovská Z; Kovaľ J; Fedoročko P
Int J Oncol; 2015 Oct; 47(4):1572-84. PubMed ID: 26252082
[TBL] [Abstract] [Full Text] [Related]
18. The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits npm/ALK-driven cell expansion and NF-κB-driven tumour intravasation.
Unger C; Kiss I; Vasas A; Lajter I; Kramer N; Atanasov AG; Nguyen CH; Chatuphonprasert W; Brenner S; Krieger S; McKinnon R; Peschel A; Kain R; Saiko P; Szekeres T; Kenner L; Hassler MR; Diaz R; Frisch R; Dirsch VM; Jäger W; de Martin R; Bochkov VN; Passreiter CM; Peter-Vörösmarty B; Mader RM; Grusch M; Dolznig H; Kopp B; Zupko I; Hohmann J; Krupitza G
Phytomedicine; 2015 Aug; 22(9):862-74. PubMed ID: 26220634
[TBL] [Abstract] [Full Text] [Related]
19. Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer.
Shilpi A; Parbin S; Sengupta D; Kar S; Deb M; Rath SK; Pradhan N; Rakshit M; Patra SK
Chem Biol Interact; 2015 May; 233():122-38. PubMed ID: 25839702
[TBL] [Abstract] [Full Text] [Related]
20. The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection.
Kadri D; Crater AK; Lee H; Solomon VR; Ananvoranich S
Exp Parasitol; 2014 Oct; 145():135-44. PubMed ID: 25128801
[TBL] [Abstract] [Full Text] [Related]
[Next]
